Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.24 - $0.37 $4,414 - $6,805
-18,392 Reduced 10.96%
149,408 $38,000
Q1 2023

May 15, 2023

SELL
$0.32 - $0.68 $17,920 - $38,080
-56,000 Reduced 25.02%
167,800 $53,000
Q4 2022

Feb 14, 2023

SELL
$0.35 - $1.26 $37,135 - $133,686
-106,100 Reduced 32.16%
223,800 $93,000
Q3 2022

Nov 14, 2022

SELL
$1.12 - $3.12 $19,600 - $54,600
-17,500 Reduced 5.04%
329,900 $321,000
Q2 2022

Aug 15, 2022

SELL
$2.76 - $7.65 $94,667 - $262,395
-34,300 Reduced 8.99%
347,400 $1.01 Million
Q1 2022

May 16, 2022

BUY
$5.63 - $13.88 $460,534 - $1.14 Million
81,800 Added 27.28%
381,700 $2.87 Million
Q4 2021

Feb 14, 2022

BUY
$13.23 - $26.05 $2.63 Million - $5.18 Million
198,700 Added 196.34%
299,900 $4.19 Million
Q3 2021

Nov 15, 2021

BUY
$25.87 - $46.61 $2.35 Million - $4.24 Million
91,000 Added 892.16%
101,200 $2.62 Million
Q2 2021

Aug 16, 2021

SELL
$39.76 - $64.31 $11,928 - $19,293
-300 Reduced 2.86%
10,200 $467,000
Q1 2021

May 17, 2021

SELL
$30.5 - $74.14 $308,050 - $748,814
-10,100 Reduced 49.03%
10,500 $462,000
Q4 2020

Feb 16, 2021

SELL
$29.39 - $35.0 $549,593 - $654,500
-18,700 Reduced 47.58%
20,600 $634,000
Q3 2020

Nov 16, 2020

BUY
$20.49 - $33.58 $805,256 - $1.32 Million
39,300 New
39,300 $1.25 Million

Others Institutions Holding AMTI

# of Institutions
1
Shares Held
9.42K
Call Options Held
0
Put Options Held
0

About Applied Molecular Transport Inc.


  • Ticker AMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,900,600
  • Description
  • Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...
More about AMTI
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.